Trial Profile
Enbrel (Etanercept) Administration to Patients Newly Diagnosed With Type 1 Diabetes Mellitus: Feasibility-Safety Study ('Study').
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 May 2023
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 01 Jul 2009 Results published in Diabetes Care.
- 01 Jul 2009 Trial stopped early because of slow recruitment.
- 01 Jul 2009 Primary endpoint 'Percent change in proportion of glycosylated haemoglobin' has been met.